Varex Imaging (NASDAQ:VREX) Issues Q1 Earnings Guidance

Varex Imaging (NASDAQ:VREX) issued an update on its first quarter earnings guidance on Tuesday morning. The company provided EPS guidance of $(0.05)-$0.10 for the period, compared to the consensus EPS estimate of $0.02. The company issued revenue guidance of $195-215 million, compared to the consensus revenue estimate of $186.50 million.

Varex Imaging Stock Up 3.1 %

VREX traded up $0.44 on Tuesday, hitting $14.56. The company had a trading volume of 1,202,387 shares, compared to its average volume of 489,282. Varex Imaging has a 12-month low of $10.19 and a 12-month high of $21.50. The stock has a market capitalization of $595.50 million, a price-to-earnings ratio of 19.89 and a beta of 0.53. The company has a debt-to-equity ratio of 0.67, a quick ratio of 1.89 and a current ratio of 3.34. The stock has a fifty day moving average price of $12.35 and a 200-day moving average price of $13.46.

Analyst Ratings Changes

Separately, B. Riley initiated coverage on Varex Imaging in a research report on Friday, August 23rd. They set a “buy” rating and a $21.00 price target on the stock.

About Varex Imaging

Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. The company operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers.